Gilead Sciences to Release First Quarter 2023 Financial Results on Thursday, April 27, 2023
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2023 financial results will be released on Thursday, April 27, 2023 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead's management will host a webcast to discuss the company's first quarter 2023 financial results and provide a business update.
A live webcast will be available on the Investor Relations section of www.gilead.com and will be archived there for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company's website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
Jennifer Mersereau, Senior Partner, Co-Founder & COO, Hamilton ETFs, Patrick Sommerville, Senior Partner, Head of Business Development, Hamilton ETFs, and their team joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange , to open...
New research insights from Info-Tech Tech Research Group will equip food and beverage manufacturers with essential strategies for embracing digital transformation. The global research and advisory firm explains that the industry can significantly...
Canadian General Investments, Limited (CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at June 30, 2024 was $62.50, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 13.3% and...
New research led by the Faculty of Health Sciences at Ontario Tech University and published in Diabetic Medicine, reveals participation in Special Olympics programming is associated with a significantly lower risk of diabetes among adults with...
The July 15 deadline approaches to be eligible for the Canada Carbon Rebate for Small Businesses. This refundable tax credit announced in Budget 2024 returns a portion of federal fuel charge proceeds directly to an estimated 600,000 small and medium...
ÉRIC & DANIEL TADROS, the visionaries behind the Liberty City real estate development, have received support from Tim Draper, a venture capitalist who initially funded Elon Musk for Tesla and SpaceX, and also supported over 20 companies that now...
